Thursday, September 17, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

GLP-1tirzepatidesesame carepricingtelehealth

Sesame Care Tirzepatide Pricing Remains Unverified, Report Says

An analysis says advertised tirzepatide costs through the telehealth marketplace could not be confirmed in 2026.

MH
By Maren Holt · Senior Reporter, GLP-1
Sep 16 15:48 ETSource: PlexusDx

The wire

  1. 01A report found Sesame Care tirzepatide pricing remains unverified as of 2026.
  2. 02Opaque pricing complicates cost comparisons for patients seeking GLP-1 drugs.
  3. 03What Sesame Care actually charges, and any response, remains unclear.

From the source

Sesame Care Tirzepatide Cost: Why Pricing Remains Unverified in 2026

Read at news.google.com